CLINICAL, DOUBLE-BLIND, RANDOMIZED, CONTROLLED WITH PLACEBO, 24 WEEKS OF DURATION THAT EVALUATES THE EFFICACY AND SAFETY OF ORAL ROFLUMILAST (250 MCG OR 500 MCG) DAILY IN PATIENTS WITH ASTHMA.

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2003
This article has no abstract
Epistemonikos ID: a640f949541c7d64ce4fc8226473fdd88f71f718
First added on: Apr 16, 2025